Status:
COMPLETED
The Effect of Palmitylethanolamide on Central and Peripheral Sensitization After Heat-induced Hyperalgesia
Lead Sponsor:
Medical University of Graz
Conditions:
Pain, Chronic
Pain, Acute
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This planned study is based on a randomized, placebo-controlled cross-over design. Palmityhlethanolamide (PEA) is an endogenous fatty acid amide from the group of N-Acetylethanolamides, which analges...
Detailed Description
Palmityhlethanolamide (PEA) is an endogenous fatty acid amide from the group of N-Acetylethanolamides, which analgesic, anti-inflammatory and neuroprotective effects can be attributed to this. It is r...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Chronic pain
- Analgesic intake
- Neurological illness
- Dermatological illness
- Cardiovascular illness
- PEA Allergy
Exclusion
Key Trial Info
Start Date :
February 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04662827
Start Date
February 9 2020
End Date
September 16 2020
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical university of Graz
Graz, Austria, 8010